미분류

Celltrion’s antibody for flu gets US patent

By 황유미
  • Published : Sept 9, 2016 - 15:36
  • Updated : Sept 9, 2016 - 15:36
[THE INVESTOR] Celltrion announced on Sept. 9 that CT-P23, its antibody to treat seasonal flu, has obtained a US patent.

This antibody neutralizes Influenza A virus and is effective in diagnosis, prevention and treatment of the virus, the biopharmaceutical company explained.

By Hwang You-mee (glamazon@heraldcorp.com)